L3HYPDH Inhibitors
L3HYPDH Inhibitors encompass a range of compounds that affect this enzyme's activity by targeting various biochemical processes. Some compounds exert their influence by disrupting key metabolic pathways that are intricately connected to the functional state of L3HYPDH. For instance, intermediates of the Krebs cycle can perturb the balance of this pathway, leading to alterations in the metabolic environment that indirectly affect the enzyme's activity. Compounds that can modify critical amino acid residues, such as those that add a methyl group or irreversibly inactivate enzyme active sites, can directly impact the catalytic function of L3HYPDH. The enzyme's activity may also be susceptible to changes in the cellular redox state, influenced by compounds that alter the NADH/NAD+ ratio, potentially affecting redox-sensitive mechanisms within L3HYPDH.
Additionally, the enzyme's activity could be inhibited by compounds that modify or deplete necessary cofactors or substrates. Competitive inhibition scenarios arise when an excess of a cofactor for other enzymes competes with L3HYPDH's function, while compounds that bind to and modify vicinal thiols could inactivate cofactor binding sites or catalytic domains, rendering the enzyme less effective or completely inactive. Non-competitive inhibitors may bind to L3HYPDH at sites other than the active site, leading to allosteric changes that reduce enzyme activity without directly blocking substrate binding. Furthermore, inhibitors that interfere with the enzyme's post-translational modifications, such as phosphorylation or glycosylation, could also play a role in diminishing L3HYPDH's functional capacity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Succinic acid | 110-15-6 | sc-212961B sc-212961 sc-212961A | 25 g 500 g 1 kg | $45.00 $75.00 $133.00 | ||
This dicarboxylic acid is involved in the Krebs cycle, a central metabolic pathway. L3HYPDH participates in amino acid metabolism, and the accumulation of intermediates such as succinic acid can indicate a disruption in metabolic flux, potentially decreasing the availability of substrates for L3HYPDH. | ||||||
Fumaric acid | 110-17-8 | sc-250031 sc-250031A sc-250031B sc-250031C | 25 g 100 g 500 g 2.5 kg | $43.00 $57.00 $114.00 $228.00 | ||
This Krebs cycle intermediate can affect the balance of the cycle and related metabolic processes. An imbalance in such cycle intermediates could influence the metabolic state of the cell, indirectly affecting the activity of L3HYPDH through alterations in cellular metabolism. | ||||||
Dimethyl fumarate | 624-49-7 | sc-239774 | 25 g | $28.00 | 6 | |
Known to modify cysteine residues on proteins through the addition of a methyl group, dimethyl fumarate could potentially modify L3HYPDH, leading to an inhibition of its enzymatic activity. | ||||||
Hydroxylamine solution | 7803-49-8 | sc-250136 | 100 ml | $72.00 | ||
This compound can irreversibly inactivate enzymes by modifying amino groups. If L3HYPDH has critical lysine residues in its active site, hydroxylamine could directly inhibit its enzymatic activity. | ||||||
Phenylhydrazine | 100-63-0 | sc-250701 sc-250701A | 5 g 100 g | $45.00 $52.00 | ||
It covalently modifies pyridoxal phosphate, a cofactor for many enzymes. If L3HYPDH relies on pyridoxal phosphate for its activity, phenylhydrazine could inhibit its function. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
As an inhibitor of dihydrofolate reductase, methotrexate leads to a depletion of tetrahydrofolate, a cofactor in one-carbon metabolism. This could indirectly inhibit L3HYPDH by depleting necessary cofactors for enzymatic reactions in which L3HYPDH is involved. | ||||||
L-Ascorbic acid, free acid | 50-81-7 | sc-202686 | 100 g | $46.00 | 5 | |
A cofactor for many hydroxylation reactions. Excess of L-ascorbic acid might competitively inhibit L3HYPDH if it has overlapping substrate specificities with other hydroxylases that use L-ascorbic acid as a cofactor. | ||||||
Sodium (meta)arsenite | 7784-46-5 | sc-250986 sc-250986A | 100 g 1 kg | $108.00 $780.00 | 3 | |
It binds to vicinal thiols, potentially inhibiting enzymes with critical dithiol-containing active sites. If L3HYPDH has such sites, this compound could directly inhibit its activity. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Inhibits ribonucleotide reductase, leading to a decrease in deoxyribonucleotide pools. If the catalytic activity of L3HYPDH is sensitive to nucleotide levels, hydroxyurea could indirectly inhibit its activity. | ||||||